Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin.
about
Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapyThe effect of electroporation pulses on functioning of the heartElectrochemotherapy: aspects of preclinical development and early clinical experienceRecommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review.Electrochemotherapy: from the drawing board into medical practiceWest Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.Developments in Intralesional Therapy for Metastatic MelanomaEffect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcomaDose-dependent thresholds of 10-ns electric pulse induced plasma membrane disruption and cytotoxicity in multiple cell lines.Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.Electrochemotherapy for treatment of skin and soft tissue tumours. Update and definition of its role in multimodal therapy.Selective cytotoxicity of intense nanosecond-duration electric pulses in mammalian cells.Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery.Efficiency of cellular delivery of antisense peptide nucleic acid by electroporation depends on charge and electroporation geometry.Use of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations.Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanomaManagement of cutaneous metastases using electrochemotherapyHigh-efficiency gene transfer into skeletal muscle mediated by electric pulses.Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strengthIntradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.Delivery of interleukin-15 to B16 melanoma by electroporation leads to tumor regression and long-term survivalUse of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanomaRole of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors.Bleomycin and the skin.Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases.Plasma-activated air mediates plasmid DNA delivery in vivo.Current status of hyperthermic limb perfusion for in-transit melanoma.Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene.Microsecond and nanosecond electric pulses in cancer treatments.Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy.Treatment of metastatic melanoma with electrochemotherapy.Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy.Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy.Intralesional therapy for metastatic melanoma.Mechanisms of transfer of bioactive molecules through the cell membrane by electroporation.Calcium electroporation induces tumor eradication, long-lasting immunity and cytokine responses in the CT26 colon cancer mouse model.Activated air produced by shielded sliding discharge plasma mediates plasmid DNA delivery to mammalian cells.The controversial role of electrochemotherapy in head and neck cancer: a systematic review of the literature.Nanosecond pulsed electric fields modulate the expression of Fas/CD95 death receptor pathway regulators in U937 and Jurkat Cells.
P2860
Q21245874-1957F6E1-2A0F-4E3F-8517-82B1CC0A1F11Q24652659-2D7B096D-F80C-498E-A1E4-3823975C4B54Q24681403-E81F09D7-9426-46B4-873D-1CC85747BA3DQ26749119-9E769D1A-2A01-45A8-A528-286232634C9CQ26863455-99683B98-4C26-403C-86C4-7498ABF19D9FQ27469785-920D28BF-8135-4551-A17F-BAEDB7BBF115Q28069615-C7163217-D15E-401C-98F2-BF597C41381CQ33814547-FC8DDE43-5626-46AB-BB07-C32AA0AE3F67Q33841941-32FF17D6-F34F-4B26-AB79-8F812F0F77DDQ34020065-72DF0063-A0C5-4F58-B3C5-BBFFAD1BFA78Q34022431-5B206C91-7C7B-424E-84F9-BABF56127008Q34025351-AD7FD478-EA47-419F-AFDC-48E9B617713EQ34107635-BDDE7835-FDA8-4D76-9FED-2758D5182015Q34534003-FD4428D3-5E9D-4DAF-A5F3-2DBEF34B3345Q34610285-E22F6845-241A-46FC-AF67-6E0D34D0A52CQ34643782-E0D780DE-2CC1-40B8-B084-979B2AE10481Q34887442-C26FAEB2-28BD-4E2E-BBE4-F828D62B35A1Q35089988-AA1A97F0-02DC-4EAD-8806-5AFE2132724FQ35123357-2841E8F3-2B32-4C7F-8A91-9CB8B2462031Q35325077-BB71ABFC-18D2-4646-B927-5EE40A692E19Q35890518-21DDC26B-0EAB-491B-9383-4D6F0298A596Q35924037-C3CF78F8-690D-44A9-9783-0A305BFC9B28Q36112819-07D5148B-471B-4771-A30F-EF5D188D04A9Q36499217-1388D164-0170-44F4-8D40-E105C3C8FBD1Q36620749-F10E4A66-AC97-4510-9438-6436EE57E09AQ36671522-C62D2AE0-FB69-47F3-BF3E-DC46AC2C0131Q36794649-94B392D7-97CD-4F80-BB84-FC5991BF5AA0Q37130240-D30819D8-D56C-4DB3-9BAD-8957EA11E5A0Q37153089-0AAA6B65-6ED6-453C-AA38-F22E30CAA978Q37910836-354AE300-9D28-4623-B41A-5C7A6237C28CQ38081808-EF8366A9-18CB-4B87-90D1-0938A9C841EEQ38200101-761E6454-1E93-4575-AE75-3805C2828DF4Q38200527-54E33140-6C8E-41A0-975A-735716CAB99DQ38209607-6DC35475-86DC-4E40-A971-FF4B10785049Q38266193-4A233157-9DB7-4D6B-96AF-E4127A5DCD25Q38458324-2146FBDE-8F89-4FB6-96C6-321953570095Q38668229-CEFC77B3-0AE3-4D5C-BF55-0E9A67986C28Q38867807-2E8839D0-9A4E-4EEA-B4B0-37B0030EEEDAQ38943085-757153A4-01EE-4946-B413-C92404993035Q38946465-779647D6-B0A2-44C8-9501-CF39D2D0DB61
P2860
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Treatment of cutaneous and sub ...... using intralesional bleomycin.
@en
Treatment of cutaneous and sub ...... using intralesional bleomycin.
@nl
type
label
Treatment of cutaneous and sub ...... using intralesional bleomycin.
@en
Treatment of cutaneous and sub ...... using intralesional bleomycin.
@nl
prefLabel
Treatment of cutaneous and sub ...... using intralesional bleomycin.
@en
Treatment of cutaneous and sub ...... using intralesional bleomycin.
@nl
P2093
P2860
P1433
P1476
Treatment of cutaneous and sub ...... using intralesional bleomycin.
@en
P2093
DeConti RC
Gilbert RA
Jaroszeski MJ
Reintgen DS
P2860
P304
P356
10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W
P407
P577
1998-07-01T00:00:00Z